Jun 11, 2020
Real-World Data of Terlipressin in Hospitalized Patients in U.K. with Hepatorenal Syndrome Type 1 (HRS-1) Published in Alimentary Pharmacology and Therapeutics
Apr 07, 2020
To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units
Nov 11, 2019
Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019
Oct 21, 2019
Mallinckrodt to Present Results from its Pivotal Phase 3 CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019
Mar 01, 2019
Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List
Feb 07, 2019
Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations
Dec 31, 2018
Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations
Dec 11, 2018
Groundbreaking NYU Winthrop Study Shows Promise for Correcting Common Misdiagnoses of Hyponatremia That Can Cause Critical Patients to Deteriorate Further
Sep 24, 2018
Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End
May 10, 2018
PANTHERx® Specialty Pharmacy Selected by Otsuka to Distribute JYNARQUE
Nov 10, 2017
Rosalind Franklin University Researcher Awarded Department of Defense Grant in Effort to Save More Lives on the Battlefield
Jun 07, 2017
Avanir Pharmaceuticals Initiates Phase II Study to Evaluate AVP-786 for Treatment of Neurobehavioral Disinhibition Associated with Traumatic Brain Injury